These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 454092)
1. Monoamine oxidase inhibitors. A review of antidepressant effectiveness. Quitkin F; Rifkin A; Klein DF Arch Gen Psychiatry; 1979 Jul; 36(7):749-60. PubMed ID: 454092 [TBL] [Abstract][Full Text] [Related]
2. MAOIs in the contemporary treatment of depression. Thase ME; Trivedi MH; Rush AJ Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and Adverse Effects of Tranylcypromine and Tricyclic Antidepressants in the Treatment of Depression: A Systematic Review and Comprehensive Meta-analysis. Ulrich S; Ricken R; Buspavanich P; Schlattmann P; Adli M J Clin Psychopharmacol; 2020; 40(1):63-74. PubMed ID: 31834088 [TBL] [Abstract][Full Text] [Related]
4. Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia. Pohl R; Berchou R; Rainey JM J Clin Psychopharmacol; 1982 Dec; 2(6):399-407. PubMed ID: 7174863 [TBL] [Abstract][Full Text] [Related]
5. Differential response patterns to MAO inhibitors and tricyclics. Nies A J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487 [TBL] [Abstract][Full Text] [Related]
6. Monoamine oxidase inhibitors. Lippmann S Am Fam Physician; 1986 Jul; 34(1):113-9. PubMed ID: 3728254 [TBL] [Abstract][Full Text] [Related]
7. Forms of atypical depression and their response to antidepressant drugs. Davidson J; Pelton S Psychiatry Res; 1986 Feb; 17(2):87-95. PubMed ID: 3083445 [TBL] [Abstract][Full Text] [Related]
8. Treating DSM-IV depression with atypical features. Stewart JW; Thase ME J Clin Psychiatry; 2007 Apr; 68(4):e10. PubMed ID: 17474800 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients. Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P J Clin Psychiatry; 2004 Nov; 65(11):1505-10. PubMed ID: 15554763 [TBL] [Abstract][Full Text] [Related]
10. Clinical effects of abrupt withdrawal from tri-cyclic antidepressants and monoamine oxidase inhibitors after long-term treatment. Tyrer P J Affect Disord; 1984 Feb; 6(1):1-7. PubMed ID: 6231324 [TBL] [Abstract][Full Text] [Related]
11. Tranylcypromine in mind (Part II): Review of clinical pharmacology and meta-analysis of controlled studies in depression. Ricken R; Ulrich S; Schlattmann P; Adli M Eur Neuropsychopharmacol; 2017 Aug; 27(8):714-731. PubMed ID: 28579071 [TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacology of phenelzine. Robinson DS; Nies A; Ravaris CL; Ives JO; Bartlett D Arch Gen Psychiatry; 1978 May; 35(5):629-35. PubMed ID: 365127 [TBL] [Abstract][Full Text] [Related]
16. A neglected modality in psychiatric treatment--the monoamine oxidase inhibitors. Johnson WC Dis Nerv Syst; 1975 Sep; 36(9):521-5. PubMed ID: 1175468 [TBL] [Abstract][Full Text] [Related]
17. A clinical overview of monoamine oxidase inhibitors. Zisook S Psychosomatics; 1985 Mar; 26(3):240-6, 251. PubMed ID: 3887453 [No Abstract] [Full Text] [Related]
18. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo. Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065 [TBL] [Abstract][Full Text] [Related]